Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002563 · ClinicalTrials.gov registry record
SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease
A clinical trial, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- 263
- Enrollment target
NCT00002563 is a clinical trial that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 263 participants.
The verdict
NCT00002563 has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- 263 participants
- Enrollment target
Study Summary
RATIONALE: Quality-of-life assessment in patients undergoing cancer treatment may help determine the intermediate- and long-term effects of treatment on patients with cancer. PURPOSE: This clinical trial studies the impact of therapy on the health status and quality of life of patients with stage I or stage II Hodgkin's disease who are receiving radiation therapy with or without chemotherapy.
Interventions
- PROCEDURE quality-of-life assessment
- PROCEDURE psychosocial assessment and care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 1994-04 |
| Est. Completion | 2005-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002563
The ClinicalTrials.gov registry entry for NCT00002563 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 263 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which quality-of-life assessment is the first listed.
NCT00002563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002563 about?
NCT00002563 is a clinical study titled "SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease". RATIONALE: Quality-of-life assessment in patients undergoing cancer treatment may help determine the intermediate- and long-term effects of treatment on patients with cancer. PURPOSE: This clinical trial studies the impact of therapy on the health status and quality of life of patients with stage I...
What is the current status of trial NCT00002563?
This trial is currently completed. The enrollment target is 263 participants. The study started on 1994-04. Estimated completion is 2005-05.
What interventions are being tested in trial NCT00002563?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), psychosocial assessment and care (PROCEDURE).
Who is sponsoring clinical trial NCT00002563?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.